A Study to Evaluate the Safety and Effectiveness of a Silicone Hydrogel Custom Contact Lens When Compared to Alden Optical HP Sphere Lens

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

84 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-02-27

Study Completion Date

2019-08-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study is to evaluate the safety and efficacy of Bausch + Lomb custom samfilcon B (test) lens compared to the hioxifilcon D, 54% water, Alden Optical HP Sphere (control) lens when worn by participants who wear soft contact lens on a daily basis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of an Investigational Frequent Replacement Silicone Hydrogel Lens

NCT04085328

Refractive Ametropia

COMPLETED NA

Comparison of Two Marketed Silicone Hydrogel Lenses

NCT02495948

Refractive Error

COMPLETED NA

Silicone Hydrogel Soft Contact Lens 7-Day Extended Wear Basis

NCT02939950

Myopia

COMPLETED NA

Clinical Comparison of Two Daily Wear Frequent Replacement Silicone Hydrogel Soft Contact Lenses

NCT04532099

Refractive Errors Ametropia

COMPLETED NA

A Contralateral Dispensing Clinical Trial of Study Test Silicone Hydrogel Lens Against Enfilcon A Silicone Hydrogel Lens

NCT02537717

Myopia

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Contact Lens Wear

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Custom Samfilcon B Contact Lenses

Participants will wear Bausch + Lomb investigational custom samfilcon B contact lenses daily for 3 months. Participants will be provided with ReNu MultiPlus Lubricating and Rewetting Drops for use as needed during the study. Participants will store their worn study lenses in a lens case filled with Biotrue multi-purpose solution (MPS).

Group Type EXPERIMENTAL

Custom Samfilcon B Contact Lenses

Intervention Type DEVICE

Contact lens

ReNu MultiPlus Lubricating and Rewetting Drops

Intervention Type DEVICE

For use as needed during the study.

Biotrue Multi-Purpose Solution

Intervention Type DEVICE

For daily rinsing, cleaning, disinfecting, and storing their lenses in lens cases during the study.

Alden Optical HP Sphere contact lenses

Participants will wear Alden Optical HP Sphere contact lenses daily for 3 months. Participants will be provided with ReNu MultiPlus Lubricating and Rewetting Drops for use as needed during the study. Participants will store worn study lenses in a lens case filled with Biotrue MPS.

Group Type PLACEBO_COMPARATOR

Alden Optical HP Sphere Contact Lens

Intervention Type DEVICE

Hioxifilcon D, 54% water, Alden Optical HP Sphere lens

ReNu MultiPlus Lubricating and Rewetting Drops

Intervention Type DEVICE

For use as needed during the study.

Biotrue Multi-Purpose Solution

Intervention Type DEVICE

For daily rinsing, cleaning, disinfecting, and storing their lenses in lens cases during the study.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Custom Samfilcon B Contact Lenses

Contact lens

Intervention Type DEVICE

Alden Optical HP Sphere Contact Lens

Hioxifilcon D, 54% water, Alden Optical HP Sphere lens

Intervention Type DEVICE

ReNu MultiPlus Lubricating and Rewetting Drops

For use as needed during the study.

Intervention Type DEVICE

Biotrue Multi-Purpose Solution

For daily rinsing, cleaning, disinfecting, and storing their lenses in lens cases during the study.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Alden Optical® HP Sphere lens Bausch + Lomb ReNu MultiPlus® Lubricating and Rewetting Drops Bausch + Lomb Biotrue® MPS

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants must be able to read, understand, and provide written informed consent on the institutional review board (IRB)-approved informed consent form (ICF) and provide authorization as appropriate for local privacy regulations.
* Participants must have clear central corneas and be free of any anterior segment disorders in each eye.
* Participants must be myopic, require contact lens correction from -1.00 diopter (D) to -6.00 D, and wear contact lenses in each eye.
* Participants must be correctable through spherocylindrical refraction to 47 letters (0.0 logMAR) or better (distance, high-contrast) in each eye.
* Participants must be able and willing to comply with all treatment and follow-up/study procedures.
* Participants must be adapted soft contact lens wearers and agree to wear their study lenses on a daily wear basis for approximately 3 months.

Exclusion Criteria

* Participants participating in any drug or device clinical investigation within 2 weeks prior to entry into this study and/or during the period of study participation.
* Participants who are women of childbearing potential (those who are not surgically sterilized or postmenopausal), who are currently pregnant, plan to become pregnant during the study, or are breastfeeding.
* Participants who have worn gas permeable lenses in either eye within the last 30 days or who have worn polymethylmethacrylate lenses in either eye within the last 3 months.
* Participants with any systemic disease currently affecting ocular health or which, in the Investigator's opinion, may have an effect on ocular health in either eye during the course of the study.
* Participants using any systemic or topical medications that will, in the Investigator's opinion, affect ocular physiology or lens performance.
* Participants with an active ocular disease in either eye or who are using any ocular medication.
* Participants who currently wear monovision, multifocal, or toric contact lenses in either eye.
* Participants with an ocular astigmatism \>1.00 D in either eye.
* Participants with anisometropia (spherical equivalent) \>2.00 D.
* Participants with any Grade ≥2 finding in either eye during the slit lamp examination. Participants with corneal infiltrates in either eye, of any grade, are not eligible to participate in this study.
* Participants with any "present" finding during the slit lamp examination in either eye that, in the Investigator's judgment, interferes with contact lens wear.
* Participants with any scar or neovascularization within the central 6 millimeters (mm) of the cornea in either eye. Note: participants with minor peripheral corneal scarring (that does not extend into the central area), that in the Investigator's judgment, does not interfere with contact lens wear, are eligible to participate in this study.
* Participants who are aphakic in either eye.
* Participants who are amblyopic in either eye.
* Participants who have had any corneal surgery (for example, refractive surgery) in either eye.
* Participants who are allergic to any component in the study care products.
* Participants who meet any of the following criteria:

1. The participant is an employee of the investigative site.
2. The participant, or a member of the participant's household, is an ophthalmologist, an optometrist, an optician, or an ophthalmic assistant/technician.
3. The participant, or a member of the participant's household, is an employee of a manufacturer of contact lenses or contact lens care products (for example, Alcon, Bausch + Lomb, Ciba Vision, CooperVision, or Johnson \& Johnson).
4. The participant, or a member of the participant's household, is an employee of a market research firm.

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes